A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementiaShifu Xiao, Raoli He, Yun‐Cheng Wu et al.|Alzheimer s Research & Therapy|2021Cited by 200
Scalable total synthesis of saxitoxin and related natural productsYinliang Guo, Phil S. Baran, Roman Vlkolinský et al.|Nature|2025Cited by 11